Apomorphine Oromucosal Spray (Innotesto)

阿扑吗啡口腔黏膜喷雾剂 (Innotesto)

Report date: 2025/05/08 11:40:43

Base Information

Drug NameApomorphine Oromucosal Spray (Innotesto)
Drug Alias NameAPORONAporon
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor agonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[5
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesInnotesto BvbaCriceto IKM BV
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A